Home/Filings/4/0001209191-10-005477
4//SEC Filing

Anglin Robert M 4

Accession 0001209191-10-005477

CIK 0000868368other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 2:28 PM ET

Size

13.9 KB

Accession

0001209191-10-005477

Insider Transaction Report

Form 4
Period: 2010-01-28
Anglin Robert M
VP Quality & Regulatory
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-01-28+10,00010,000 total
    Exercise: $12.27From: 2011-01-28Exp: 2020-01-28Common Stock (10,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $2.34Exp: 2011-04-06Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $4.63Exp: 2014-01-02Common Stock (4,000 underlying)
    4,000
  • Stock Option (Right to Buy)

    Exercise: $10.89From: 2009-02-12Exp: 2018-02-12Common Stock (5,000 underlying)
    5,000
  • Common Stock

    600
  • Stock Option (Right to Buy)

    Exercise: $2.17Exp: 2011-10-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy)

    Exercise: $11.91From: 2007-11-29Exp: 2016-11-29Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $11.27From: 2010-02-03Exp: 2019-02-03Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]Currently 100% vested.
  • [F2]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

Entity typeother

Related Parties

1
  • filerCIK 0001450690

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 2:28 PM ET
Size
13.9 KB